论文部分内容阅读
前列腺癌发病率不断上升,是欧美国家最常见的泌尿系统恶性肿瘤,在我国位居泌尿系肿瘤第3位。该病发病机制尚不明确,大部分研究认为前列腺癌为激素依赖性肿瘤,减少雄激素的分泌对于抑制病情的发展有一定作用。目前内分泌治疗是前列腺癌晚期的一线治疗方法,对于治疗后代谢指标的变化都有相关研究,该文就前列腺癌内分泌治疗方法之一—最大限度雄激素阻断,治疗后代谢指标变化研究做一综述。
The rising incidence of prostate cancer, is the most common urinary system malignancies in Europe and the United States, ranked third in urinary tumors in our country. The pathogenesis of the disease is not clear, most studies suggest that prostate cancer is a hormone-dependent tumor, reducing androgen secretion for the inhibition of the progression of the disease have a role. Currently endocrine therapy is the first-line treatment of advanced prostate cancer, for the treatment of metabolic changes have relevant research, this article on the treatment of endocrine of prostate cancer - the maximum androgen blockade, metabolic index after treatment to do a study Summary.